• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Eraglusib Combo Improves Survival in Metastatic Pancreatic Cancer

by MM360 Staff | May 9, 2025 | Uncategorized

Source: CureToday articles Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic pancreatic ductal adenocarcinoma. Read More

A Thank You to Nurses and the Support That Lasts Beyond Cancer Care

by MM360 Staff | May 9, 2025 | Uncategorized

Source: CureToday articles After cancer, lifelong infusions were tough — until nurse Angela’s care and kindness reminded me that true support can last long after treatment ends. Read More

Imfinzi Regimen Improves Disease-Free Survival in Early Bladder Cancer

by MM360 Staff | May 9, 2025 | Uncategorized

Source: CureToday articles Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for some with bladder cancer. Read More

Breaking Down Barriers to Diagnosis in AYA Patients With Lymphoma

by MM360 Staff | May 9, 2025 | Uncategorized

Source: CureToday articles Dr. Kara Kelly discusses some of the most common challenges faced by adolescent and young adult patients with lymphoma. Read More

Biomarker Testing Remains Crucial for Young Patients With Lung Cancer

by MM360 Staff | May 8, 2025 | Uncategorized

Source: CureToday articles Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of actionable mutations. Read More

How Cancer Care Teams Can Help With the Cessation of Smoking

by MM360 Staff | May 8, 2025 | Uncategorized

Source: CureToday articles Dr. Daniel J. Boffa shared how cancer care teams support patients in quitting smoking and how new data may guide improvements in high-smoking U.S. regions. Read More
« Older Entries
Next Entries »

Recent Content

  • Correction: Chen et al. The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A Systematic Review and Meta-Analysis. Diagnostics 2024, 14, 1030
  • Comparison of Standard of Care with or Without a PD-1/PD-L-1 Inhibitor for the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled Trials
  • Combo treatment may offer new hope to astrocytoma patients: Trial
  • Reduced-versus Standard-dose Melphalan as Single-agent Conditioning Regimen in Auto HSCT for Multiple Myeloma: A Systematic Review and Meta-Analysis
  • Dosing begins in trial testing Enhertu for ovarian cancer
  • (no title)
  • (no title)
  • Teclistamab combo improves relapsed, refractory myeloma outcomes
  • Safety and Efficacy of Anti-B-cell Maturation Antigen (Anti-BCMA) Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma: A Systematic Review of Clinical Trials
  • (no title)
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT